학술논문
Outcome measures for children with speech sound disorder: an umbrella review.
Document Type
Academic Journal
Author
Harding S; Southmead Hospital, Bristol, UK sharding.jb@gmail.com.; Bristol Speech and Language Therapy Research Unit, North Bristol NHS Trust, Westbury on Trym, UK.; Burr S; Bristol Speech and Language Therapy Research Unit, North Bristol NHS Trust, Westbury on Trym, UK.; Cleland J; Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.; Stringer H; School of Education, Communication and Language Sciences, Newcastle University, Newcastle upon Tyne, UK.; Wren Y; Bristol Speech and Language Therapy Research Unit, North Bristol NHS Trust, Westbury on Trym, UK.; Bristol Dental School, University of Bristol, Bristol, UK.
Source
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Subject
Language
English
Abstract
Objective: Speech sound disorder (SSD) describes a 'persistent difficulty with speech sound production that interferes with speech intelligibility or prevents verbal communication'. There is a need to establish which care pathways are most effective and efficient for children with SSD. Comparison of care pathways requires clearly defined, evidence-based, interventions and agreement on how to measure the outcomes. At present, no definitive list of assessments, interventions or outcomes exists. The objective of this umbrella review paper is to provide a rigorous and detailed list of assessments, interventions and outcomes which target SSD in children.
Design: In December 2022, a systematic search of Ovid Medline, OVID Embase, CINAHL, PsycInfo and Cochrane and a number of grey literature platforms were undertaken. 18 reviews were included, and subsequently 415 primary research articles were assessed for data related to assessments, interventions or outcomes. The AMSTAR (Assessing the Methodological Quality of Systematic Reviews) framework was used to assess the quality of the retained reviews.
Setting: Reviews were retained which took place in any setting.
Participants: The population is children of any age with a diagnosis of SSD of unknown origin.
Primary and Secondary Outcome Measures: Reviews reporting outcomes, assessment and interventions for children with SSD.
Results: Extraction and analysis identified 37 assessments, 46 interventions and 30 outcome measures used in research reporting of SSD. Not all of the listed outcomes were linked to specific outcome measurement tools, but these were measurable through the use of one or more of the assessments extracted from the retained reviews.
Conclusions: The findings of this review will be used to develop a Core Outcome Set for children with SSD. The findings are part of a rigorous process essential for advancing healthcare research and practice in the specific area of speech and language therapy for children with SSD.
Prospero Registration Number: CRD42022316284.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Design: In December 2022, a systematic search of Ovid Medline, OVID Embase, CINAHL, PsycInfo and Cochrane and a number of grey literature platforms were undertaken. 18 reviews were included, and subsequently 415 primary research articles were assessed for data related to assessments, interventions or outcomes. The AMSTAR (Assessing the Methodological Quality of Systematic Reviews) framework was used to assess the quality of the retained reviews.
Setting: Reviews were retained which took place in any setting.
Participants: The population is children of any age with a diagnosis of SSD of unknown origin.
Primary and Secondary Outcome Measures: Reviews reporting outcomes, assessment and interventions for children with SSD.
Results: Extraction and analysis identified 37 assessments, 46 interventions and 30 outcome measures used in research reporting of SSD. Not all of the listed outcomes were linked to specific outcome measurement tools, but these were measurable through the use of one or more of the assessments extracted from the retained reviews.
Conclusions: The findings of this review will be used to develop a Core Outcome Set for children with SSD. The findings are part of a rigorous process essential for advancing healthcare research and practice in the specific area of speech and language therapy for children with SSD.
Prospero Registration Number: CRD42022316284.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)